Indicators

Markets:

News

Latest News about wegovy

Recent news which mentions wegovy

< Previous 1 2 3 4 Next >

What's Going On With Hims & Hers Shares Today?

August 19, 2025

Novo Nordisk Surges On Wegovy Win, Eyes Bullish Rebound Near 52-Week Lows

August 18, 2025

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

July 26, 2025

Wegovy, Zepbound Prices Drop, But Most Patients Still Can't Afford Long-Term Use: 'Coverage Is Not The Same As Access,' Says Expert

July 07, 2025

HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?

June 24, 2025

McDonald's Just Got Hammered By Weight-Loss Drugs — Twice

June 11, 2025

Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial

May 12, 2025

Novo Nordisk Says Its 'Wegovy In A Pill' Delivers Big: '16.6% Average' Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity

May 08, 2025

Hims & Hers: The Next Amazon? Novo Nordisk Might Be Prime Delivery

May 05, 2025

Netflix, UnitedHealth, Novo Nordisk, Tesla And Trump Media: Why These 5 Stocks Are On Investors' Radars Today

April 17, 2025

Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report

March 06, 2025

Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials

March 06, 2025

RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders

January 29, 2025

Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?

December 26, 2024

EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss

December 20, 2024

Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance

December 03, 2024

Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs

November 26, 2024

As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%

November 04, 2024

Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why

October 30, 2024

Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'

October 23, 2024

Novo Nordisk's Death Cross: Is A Turnaround Coming For The Ozempic, Wegovy Maker?

October 23, 2024

Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?

October 22, 2024

Latest Inflation Data Cements Fed's Interest Rate Call, S&P 500 Hits All-Time High, Biden Adviser Backs China EV Ban At Detroit Economic Club: This Week In The Markets

September 27, 2024

EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'

September 25, 2024

Novo Nordisk To Consider Ways For Patients To Affordably Access Weight Loss Drugs Ozempic, Wegovy, Says CEO

September 24, 2024

'Miracle' Weight Loss Drug Ozempic To Enter US Price Negotiations Within A Year, Novo Nordisk CEO Says Ahead Of Senate Hearing

September 24, 2024

Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100

September 22, 2024

Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential

August 31, 2024

Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle

August 21, 2024

Weight-Loss Giant Novo Nordisk Tumbles To 200-Day Average Support: 'Weakness Could Be Buying Opportunity,' Analyst Says

August 07, 2024

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.